Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,658,367 papers from all fields of science
Search
Sign In
Create Free Account
LBQ657
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Aminobutyrates
Biphenyl Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Radiosynthesis of the 11 C-methyl derivative of LBQ657 for PET investigation of the neprilysin inhibitor sacubitril.
V. Teyssier
,
J. Simard
,
M. Dornan
,
F. Tournoux
,
J. DaSilva
Journal of labelled compounds…
2020
Corpus ID: 210087136
Neprilysin, also known as neutral endopeptidase, is a cell surface membrane metalo-endopeptidase that cleaves various peptides…
Expand
2019
2019
P3829Antiarrhythmic effects of Sacubitrilat (LBQ657) on Ca2+ homeostasis in ventricular cardiomyocytes
J. Eiringhaus
,
C. Wuensche
,
Jonas Herting
,
G. Hasenfuss
,
S. Sossalla
,
T. Fischer
European Heart Journal
2019
Corpus ID: 208471192
Simultaneous inhibition of neprilysin and angiotensin II receptors by sacubitril/valsartan was shown to significantly…
Expand
2019
2019
Effects of Sacubitril/Valsartan on myocardial remodeling and cardiac function in rats with myocardial infarction
Huiyao Lu
,
Xunfa Xu
,
Jiayin Guo
,
Wenan Zhao
,
Zhimin Lin
2019
Corpus ID: 219847658
Objective To explore the effect and mechanism of Sacubitril/Valsartan on myocardial remodeling and cardiac function in rats with…
Expand
2016
2016
Assessment of Drug–Drug Interaction Potential Between Atorvastatin and LCZ696, A Novel Angiotensin Receptor Neprilysin Inhibitor, in Healthy Chinese Male Subjects
S. Ayalasomayajula
,
W. Pan
,
+7 authors
G. Sunkara
European journal of drug metabolism and…
2016
Corpus ID: 256097374
LCZ696 (sacubitril/valsartan), a novel angiotensin receptor neprilysin inhibitor has been recently approved for the treatment of…
Expand
Review
2016
Review
2016
March 15 , 2016 by blocking vascular and adrenal
Scott A. Hubers
,
N. Brown
2016
Corpus ID: 207783308
1115 Abstract—Heart failure affects ≈5.7 million people in the United States alone. Angiotensin-converting enzyme inhibitors…
Expand
2016
2016
Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
S. Ayalasomayajula
,
T. Langenickel
,
+6 authors
G. Sunkara
European Journal of Clinical Pharmacology
2016
Corpus ID: 253781374
LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor, is indicated for chronic heart failure (HF) and…
Expand
2015
2015
LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure
M. Lefkowitz
BMC Pharmacology and Toxicology
2015
Corpus ID: 256366230
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required